These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12032178)

  • 1. Novel concepts in understanding and management of glomerular proteinuria.
    Reiser J; von Gersdorff G; Simons M; Schwarz K; Faul C; Giardino L; Heider T; Loos M; Mundel P
    Nephrol Dial Transplant; 2002 Jun; 17(6):951-5. PubMed ID: 12032178
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA; Abraham PA; Keane WF
    Drugs; 1990; 39 Suppl 2():23-32. PubMed ID: 2188823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pros and cons of plasmapheresis therapy carried out on time.
    Izquierdo-Ortiz MJ; Mercado-Valdivia V; Camarero-Temiño V; Hijazi-Prieto B; Saiz-Calero I; Angola-Muquel MC; Muñoz-Merino M; Rodríguez-Velasco B; Abaigar-Luquin P
    Nefrologia; 2013; 33(5):741-2. PubMed ID: 24089171
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal protection: progression, regression, remission from nephropathy beyond blood pressure control.
    Remuzzi G
    Int J Clin Pract Suppl; 2000 May; (110):9-15. PubMed ID: 10912302
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic accuracy of the protein/creatinine ratio in urine samples to estimate 24-h proteinuria in patients with primary glomerulopathies: a longitudinal study.
    Antunes VV; Veronese FJ; Morales JV
    Nephrol Dial Transplant; 2008 Jul; 23(7):2242-6. PubMed ID: 18281321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REIN on obesity, proteinuria and CKD.
    Choi ME
    J Am Soc Nephrol; 2011 Jun; 22(6):990-2. PubMed ID: 21617125
    [No Abstract]   [Full Text] [Related]  

  • 8. Halting the progression of renal disease: where we stand?
    Campbell RC; Remuzzi G
    Nefrologia; 2002; 22(4):303-5. PubMed ID: 12369119
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of different converting-enzyme inhibitors on the course of non-diabetic glomerulopathies.
    Bernheim J
    Nephrol Dial Transplant; 1990; 5(10):837-40. PubMed ID: 2128376
    [No Abstract]   [Full Text] [Related]  

  • 10. The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.
    Schieppati A; Remuzzi G
    Kidney Int; 2003 Dec; 64(6):1947-55. PubMed ID: 14633117
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteinuria in special populations: pregnant women and children.
    Hladunewich MA; Schaefer F
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):267-72. PubMed ID: 21782133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowing nephropathy progression: focus on proteinuria reduction.
    Bakris GL
    Clin J Am Soc Nephrol; 2008 Jan; 3 Suppl 1(Suppl 1):S3-10. PubMed ID: 18178794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic measures in proteinuric nephropathy.
    Praga M
    Kidney Int Suppl; 2005 Dec; (99):S137-41. PubMed ID: 16336567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
    Linas SL
    Clin J Am Soc Nephrol; 2008 Jan; 3 Suppl 1(Suppl 1):S17-23. PubMed ID: 18178792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic concepts of proteinuria and intra-glomerular hypertension.
    Woo KT
    Singapore Med J; 1998 Jun; 39(6):271-2. PubMed ID: 9803817
    [No Abstract]   [Full Text] [Related]  

  • 16. Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.
    Venkat KK
    South Med J; 2004 Oct; 97(10):969-79. PubMed ID: 15558924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease.
    Remuzzi A; Gagliardini E; Sangalli F; Bonomelli M; Piccinelli M; Benigni A; Remuzzi G
    Kidney Int; 2006 Apr; 69(7):1124-30. PubMed ID: 16395266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin blockade as sole treatment for proteinuric kidney disease in children.
    Chandar J; Abitbol C; Montané B; Zilleruelo G
    Nephrol Dial Transplant; 2007 May; 22(5):1332-7. PubMed ID: 17299000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta.
    Tahir H; Jackson LL; Warnock DG
    J Am Soc Nephrol; 2007 Sep; 18(9):2609-17. PubMed ID: 17656478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.